Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Norberto Fischer as New Company Spokesperson

SAN DIEGO, June 20, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that Norberto Fischer has joined as spokesperson for the company.

“We’re very excited to have Norberto, a very close friend of the company, join us as a spokesperson and help share his story about how CBD helps improve the quality of life for his daughter, Anny,” said HempMeds® Brasil Vice President Caroline Heinz. “Norberto is not only passionate, but he is knowledgeable and well-recognized within Brazil’s cannabis community.”

Fischer and his wife Katiele first became involved in the cannabis industry when they received the first National Agency of Sanitary Surveillance (Anvisa)-authorized import permit for cannabidiol (CBD) in Brazil for their daughter Anny. Anny suffers from a rare genetic disorder called CDKL5 that causes seizures. Once Norberto and Katiele realized that prescription medications wouldn’t stop Anny’s seizures, they discovered the Facebook page and story of Harper Howard, a girl in the U.S. who was taking CBD for CDKL5.

The Fischers became interested in giving CBD to Anny, but all forms of cannabis were banned in Brazil at the time, preventing them from legally pursuing the treatment option. They then found themselves forced to fight for access to CBD for their daughter, suing the government in Brazil for the right to import CBD for Anny. Three days later, they became the first to receive an authorized import permit for CBD from Anvisa. Within the first three months of taking CBD, Anny went from having 64 seizures a week to zero.

“I’m excited to represent a company that has brought my family and many families across the world great benefits and joy,” said HempMeds® Brasil Spokesperson Norberto Fischer. “I hope that I

Bookmark the permalink.